• Matthew S. Karafin, MD, MS
  Dr. Matthew Karafin has been an Associate Medical Director for the BloodCenter of Wisconsin since 2012, after completing his transfusion medicine fellowship and pathology residency at the Johns Hopkins Hospital. Dr. Karafin’s major clinical responsibilities include managing the blood bank and the therapeutic apheresis service for the Froedtert Hospital/Medical College of Wisconsin in Milwaukee, and educating residents and fellows in transfusion medicine. Dr. Karafin is a passionate advocate for patients with sickle cell disease; he directs the red cell exchange program for the Adult Sickle Cell Clinic at Froedtert Hospital, and his research focus of the last three years has been in improving transfusion support for patients with sickle cell disease.
  
  Affiliation: Associate Medical Director, Medical Sciences Institute: BloodCenter of Wisconsin. Assistant Professor of Pathology, Medical College of Wisconsin, Milwaukee, WI
• Cheryl Mather, MD
  

  Dr. Cheryl Mather was the Molecular Genetic Pathology Fellow at the University of California, San Francisco. She trained in anatomic pathology, clinical pathology, and gastrointestinal pathology at the University of Washington in Seattle. While in Seattle, Dr. Mather completed an acting directorship in the clinical microbiology laboratory and published work on the identification of mycobacteria and vancomycin-intermediate Staphylococcus aureus using matrix-assisted laser desorption-ionization/time-of-flight mass spectrometry (MALDI-TOF MS). She has also worked on the identification of oncogenic viruses in targeted sequencing data.
  
  Affiliation: Assistant Clinical Professor, Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada

Bone

• David G. Hicks, MD
  

  David G. Hicks, MD, is the Director of Surgical Pathology at the University of Rochester Medical Center. Dr. Hicks' innovative approaches to improving efficiency and quality in surgical pathology have been highlighted in publications and invited lectures sponsored by national pathology organizations. His organizational interests are in the development of a subspecialty-based surgical pathology system, combining disease-specific diagnostic and prognostic expertise with translational research based on organ systems and disease categories. Dr. Hicks' first research interest was in bone pathology. He received NIH funding to study the effects of lead on the epiphyseal plate, and collaborated on related studies with faculty in the Department of Orthopaedics at the University of Rochester. He published extensively on metabolic and neoplastic bone disorders. While Director of Surgical Pathology and Co-director of the Morphologic Molecular Pathology translation research resource at the Cleveland Clinic, he expanded his interests in breast pathology, with particular focus on prognostic molecular markers in breast cancer and development of advanced tissue-based diagnostic techniques.
  
  Affiliation: Director of Surgical Pathology, University of Rochester Medical Center, Rochester, NY

Breast

• Linda M. Schiffhauer, MD
  Attending Surgical Pathologist, Breast Subspecialty Service; Associate Director, Pathology Residency Program; Co-Director, Surgical Pathology Resident Rotation; Associate Professor of Pathology, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center and School of Medicine and Dentistry, Rochester, NY

Cardiovascular and Thoracic

• Mary Beth Beasley, MD
  Associate Professor of Pathology, The Mount Sinai Hospital, New York, NY

Clinical Chemistry

• Melkon DomBourian, MD
  

  Dr. Melkon G. DomBourian is an Assistant Professor of Pathology at the University of Colorado. He serves as the Medical Director of Clinical Chemistry and Point of Care Testing as well as the Associate Medical Director of Transfusion Medicine Services at the Children’s Hospital Colorado. He graduated from the University of Wisconsin School of Medicine and completed a residency in anatomic and clinical pathology at the University of Colorado. He then completed fellowships in chemical pathology and blood banking/transfusion medicine at the William Beaumont Hospital in Royal Oak, MI. He is board-certified in anatomic pathology, clinical pathology, chemical pathology, and blood banking/transfusion medicine.
  
  Affiliation: Medical Director, Clinical Chemistry and Point of Care Testing; Associate Medical Director, Transfusion Medicine Services Children’s Hospital Colorado; Assistant Professor of Pathology, University of Colorado School of Medicine, Aurora, CO.

Cytopathology

• Savitri Krishnamurthy, MD
  Professor of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dermatopathology

• Bruce Smoller, MD
  Professor and Chair, Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY

Forensics and Autopsy

• Rebecca Irvine, MD
  Senior Staff Specialist, Forensic Pathology, Department of Forensic Medicine, Sydney, Australia
• Harold Sanchez, MD
  Associate Chief of Pathology, Hospital of Central Connecticut, New Britain, CT

Gastrointestinal

• Alexandros D. Polydorides, MD, PhD
  

  Dr. Alexandros D. Polydorides is an assistant professor of pathology at the Mount Sinai School of Medicine and an attending pathologist in the Division of Gastrointestinal Pathology at the Mount Sinai Hospital in New York City. He has authored or co-authored numerous peer-reviewed publications and book chapters, and regularly presents abstracts at international pathology meetings where he is often invited to lecture on various topics in gastrointestinal pathology. A native of Athens, Greece, Dr. Polydorides graduated from Princeton University (Molecular Biology and Biomedical Engineering) in 1995 and the Tri-Institutional MD/PhD program in 2003, obtaining his MD from Weil Cornell Medical College and his PhD from Rockefeller University where he studied neuronal RNA-binding proteins in the laboratory of Dr. Robert B. Darnell. He completed his Residency in Anatomic Pathology at New York Presbyterian Hospital/Weil Cornell Medical Center in 2006, followed by fellowships in oncologic surgical pathology at Memorial Sloan-Kettering Cancer Center and in gastrointestinal pathology at the University of Michigan where he trained under Dr. Henry D. Appelman. Dr. Polydorides has been the recipient of numerous awards and distinctions throughout his academic career. He is an active member of many academic pathology societies and a regular reviewer of articles submitted for publication to distinguished pathology journals. He continues to collaborate as an investigator in many funded research programs as well as to participate in the teaching and training of medical students, residents, and fellows.
  
  Affiliation: Assistant Professor of Pathology, Mount Sinai School of Medicine; Attending Pathologist, Division of Gastrointestinal Pathology, Mount Sinai Hospital, New York, NY

General Topics

• Alexandros D. Polydorides, MD, PhD
  

  Dr. Alexandros D. Polydorides is an assistant professor of pathology at the Mount Sinai School of Medicine and an attending pathologist in the Division of Gastrointestinal Pathology at the Mount Sinai Hospital in New York City. He has authored or co-authored numerous peer-reviewed publications and book chapters, and regularly presents abstracts at international pathology meetings where he is often invited to lecture on various topics in gastrointestinal pathology. A native of Athens, Greece, Dr. Polydorides graduated from Princeton University (Molecular Biology and Biomedical Engineering) in 1995 and the Tri-Institutional MD/PhD program in 2003, obtaining his MD from Weil Cornell Medical College and his PhD from Rockefeller University where he studied neuronal RNA-binding proteins in the laboratory of Dr. Robert B. Darnell. He completed his Residency in Anatomic Pathology at New York Presbyterian Hospital/Weil Cornell Medical Center in 2006, followed by fellowships in oncologic surgical pathology at Memorial Sloan-Kettering Cancer Center and in gastrointestinal pathology at the University of Michigan where he trained under Dr. Henry D. Appelman. Dr. Polydorides has been the recipient of numerous awards and distinctions throughout his academic career. He is an active member of many academic pathology societies and a regular reviewer of articles submitted for publication to distinguished pathology journals. He continues to collaborate as an investigator in many funded research programs as well as to participate in the teaching and training of medical students, residents, and fellows.
  
  Affiliation: Assistant Professor of Pathology, Mount Sinai School of Medicine; Attending Pathologist, Division of Gastrointestinal Pathology, Mount Sinai Hospital, New York, NY

Genitourinary

• Brian D. Robinson, MD
  Assistant Professor of Pathology & Laboratory Medicine, Assistant Professor of Pathology in Urology, Weill Cornell Medical College/New York-Presbyterian Hospital, New York, NY

Gynecological

• Rochelle Simon, MD
  Associate Professor of Pathology, The George Washington University Medical Center, Washington, DC

Head & Neck / Endocrine

• Juan Hernandez-Prera, MD
  Assistant Professor of Pathology, The Mount Sinai Hospital, New York, NY

Hematology, Hemostasis, and Thrombosis

• Jeffrey S. Jhang, MD
  Dr. Jeffrey Jhang is an Associate Professor of Pathology at the Icahn School of Medicine at Mount Sinai in New York and the Director of Blood Bank and Transfusion Service for the Mount Sinai Health System. Dr. Jhang provides medical and administrative leadership as the director of the blood bank, apheresis unit, cellular therapy laboratory, and hematology and coagulation laboratory. In this role, he has enhanced the quality, safety, and efficiency of transfusion medicine and hematology services. The harmful effects, complications, and poor outcomes of blood transfusion have been the focus of his research. He has studied the negative effects of long-term storage of red blood cells in both human and mouse models of transfusion, as well as characteristics of blood donors (e.g., G6PD deficiency, hemoglobinopathies) that may be harmful to blood transfusion recipients. The goal of his research is to provide clinical evidence either in support of or against using apheresis in the treatment of human diseases. He has reported on the safety and effectiveness of apheresis in Wilson disease, heart transplant rejection, and kidney transplant rejection. In addition to his local leadership roles, he also provides leadership in the global pathology community through his professional service on national and international pathology committees and through his work in the development of educational resources. As a part of the FACT, CAP, and AABB committees, he has co-written and provided subject matter expertise on international standards for laboratory testing and stem cell collection. The FACT standards, CLSI and ISO documents, and AABB standards are used throughout the world to ensure that laboratories are providing the highest quality services. He has edited and authored book chapters and web resources that have been useful to pathologists, residents, and fellows. He is a co-editor of the Clinical Pathology Board Review book, also published by Elsevier.
  
  Affiliation: Associate Professor of Pathology, Icahn School of Medicine at Mount Sinai; Director, Blood Bank and Transfusion Services, Mount Sinai Health System, New York, NY

Hematopathology

• Jeremy C. Wallentine, MD
  Hematopathologist and Director of Molecular Diagnostics, Intermountain Healthcare Central Region Department of Pathology, Salt Lake City, UT
• Kristie L. White, MD, MAEd
  

  Kristie White, MD, MAEd, is the Director of Hematology at the University of California, San Francisco (UCSF), Benioff Children’s Hospital and the Director of Residency Training for Clinical Pathology at UCSF. She completed a master’s degree in education at the University of California, Berkeley, to gain expertise in educational methods. Dr. White's research interests include developing new technologies for use in medical education, with an emphasis on the development of assessment methods and curricula for pathology resident education. Her clinical activities include diagnostic hematopathology and hematology, with a focus on pediatric hematopathology.
  
  Affiliation: Director, Residency Training Program; Director, Hematology Laboratory at Mission Bay; Assistant Clinical Professor Department of Laboratory Medicine, University of California, San Francisco, CA

Immunology

• Patrick Michael Long, PhD
  

  P. Michael Long, PhD, is Associate Professor of Pathology at the Wayne State University School of Medicine and Technical Director of Immunodiagnostics at the Detroit Medical Center University Laboratory. He received his undergraduate degree from Villanova University and his master’s degree from Seton Hall University. He received his PhD in Immunology from the Wayne State School of Medicine and completed a tumor immunology fellowship at the Mayo Clinic Graduate School of Medicine in Rochester, MN. Specialty: Immunodeficiency, Autoimmunity, and Infectious Diseases.
  
  Affiliation: Technical Director of Immunodiagnostics, Detroit Medical Center University Laboratory; Associate Professor, Department of Pathology, Wayne State School of Medicine, Detroit, MI

Laboratory Management and Clinical Laboratory Informatics

• Paul Tranchida, MD
  

  Paul Tranchida, MD, is currently employed at the Detroit Medical Center. He graduated from the Wayne State University School of Medicine and did his anatomic and clinical pathology residencies at the Detroit Medical Center. He subsequently completed fellowships in pathology informatics and cytopathology at the Henry Ford Health System, and then returned to the Detroit Medical Center to complete one final fellowship in surgical pathology before joining the staff.
  
  Affiliation: Assistant Professor, Department of Pathology, Wayne State University School of Medicine, Detroit, MI

Medical Microbiology

• Cheryl Mather, MD
  

  Dr. Cheryl Mather was the Molecular Genetic Pathology Fellow at the University of California, San Francisco. She trained in anatomic pathology, clinical pathology, and gastrointestinal pathology at the University of Washington in Seattle. While in Seattle, Dr. Mather completed an acting directorship in the clinical microbiology laboratory and published work on the identification of mycobacteria and vancomycin-intermediate Staphylococcus aureus using matrix-assisted laser desorption-ionization/time-of-flight mass spectrometry (MALDI-TOF MS). She has also worked on the identification of oncogenic viruses in targeted sequencing data.
  
  Affiliation: Assistant Clinical Professor, Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada
• Susan Whittier, PhD, ABMM
  

  Dr. Susan Whittier, a board-certified doctoral-level scientist, is Director of the Clinical Microbiology Service at the NewYork-Presbyterian Hospital/Columbia University Medical Center and an Associate Professor of Clinical Pathology and Cell Biology at the Columbia University Medical Center. She received her PhD in microbiology and immunology from Hahnemann University in Philadelphia and went on to do her fellowship at UNC Hospital in Chapel Hill, NC. Dr. Whittier is on several editorial boards, has authored chapters on bacterial identification, and has published more than 70 research articles. Her areas of interest include emerging antibiotic resistance, implementation of molecular techniques in the clinical lab, cost-effective laboratory algorithms, detection of C. difficile, and the microbiology of cystic fibrosis patients. She is the former president of the NYC branch of the American Society of Microbiology and is a frequent lecturer at both national and international microbiology and infectious disease symposia.
  
  Affiliation: Director, Clinical Microbiology Service, NewYork-Presbyterian/Columbia University Medical Center; Associate Professor of Clinical Pathology and Cell Biology, Department of Pathology and Cell Biology, Columbia University, New York, NY

Molecular

• Aaron Auerbach, MD, MPH
  Senior Pathologist, Department of Hematopathology, Joint Pathology Center; Director of Hematacor for Bostwick Laboratories, Silver Spring, MD

Molecular Pathology and Cytogenetics

• Mark D. Ewalt, MD
  

  Mark D. Ewalt, MD, is Assistant Professor of Pathology and Laboratory Medicine and the Associate Program Director of the Molecular Genetic Pathology Fellowship at Cedars-Sinai Medical Center. Dr. Ewalt is certified in hematopathology and molecular genetic pathology, and he is interested in merging these disciplines to better understand the molecular diagnostics of myeloid neoplasms. He is actively involved in the hematopathology subdivision of the Association for Molecular Pathology (AMP) and was recently elected to serve as a member of its Teaching and Education Committee (TEC).
  
  Affiliation: Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

Neuropathology

• Gabrielle Yeaney, MD
  Division of Neuropathology, RT Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH

Pancreas, Biliary, Liver

• Huaibin Mabel Ko, MD
  Assistant Professor, Division of Gastrointestinal Pathology, Department of Pathology, The Mount Sinai Hospital, New York, NY

Pediatrics

• Jessica Comstock, MD
  Pediatric Pathologist, University of Utah Department of Pathology, Division of Pediatric Pathology, Primary Children’s Hospital, Salt Lake City, UT
• Angelica R. Putnam, MD
  Associate Professor of Pathology, University of Utah School of Medicine, Division of Pediatric Pathology, Primary Children’s Hospital, Salt Lake City, UT

Soft Tissue

• Matthew R. Lindberg, MD
  Assistant Professor, Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR

Toxicology

• Y. Victoria Zhang, PhD, DABCC
  

  Y. Victoria Zhang, PhD, DABCC, is an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Rochester Medical Center. She is Associate Director of Clinical Pathology, Director of the Clinical Mass Spectrometry and Toxicology Laboratory, and Associate Director of the Clinical Chemistry Laboratory at the Strong Memorial Hospital in Rochester. Dr. Zhang completed her clinical chemistry fellowship training at Boston Children’s Hospital, Harvard Medical School. Her research interests are in clinical applications of mass spectrometry, transitioning of late-phase discovery and ‑omics biomarkers to clinical services, and biomarker discovery for early diagnosis of disease and prognosis using ‑omics technologies. Dr. Zhang is the founding chair of the AACC Mass Spectrometry and Separation Sciences divisions, leading the national effort to enhance clinical applications of mass spectrometry for precision medicine. She is the faculty chair for the AACC Online Certificate Programs for the introductory and troubleshooting programs for LC-MS/MS. Dr. Zhang is also the chair for the AACC Asian Pacific Working Group to lead efforts to enhance the quality and practice of clinical chemistry in this region.
  
  Affiliation: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY

Transfusion Medicine

• Tammon Nash, MD
  Tammon A. Nash, MD, MS, is the System Blood Bank Medical Director for the Detroit Medical Center and Assistant Professor at Wayne State University, Detroit, MI. She is an anatomic and clinical pathology board-certified pathologist with specialty training in transfusion medicine. After completing a transfusion medicine fellowship at the BloodCenter of Wisconsin, she was a Robert Wood Johnson Clinical Scholar at the University of Michigan, Ann Arbor. Her research interests include expanding the blood donor pool and transfusion care for patients with sickle cell anemia. She has several years of experience in therapeutic apheresis, enjoys teaching residents, and looks forward to contributing more to the field of transfusion medicine.
  
  Affiliation: System Blood Bank Medical Director, Detroit Medical Center, Detroit, MI
• Geoffrey Wool, MD, PhD
  Geoffrey Wool, MD, PhD, is an Assistant Professor of Pathology at the University of Chicago. He is the Assistant Medical Director of the blood bank and the Associate Medical Director of the coagulation laboratory. He received his MD and PhD from the University of Chicago. He completed his clinical pathology residency and hematopathology fellowship at the University of California, San Francisco, and his transfusion medicine fellowship at the University of Chicago. Dr. Wool’s clinical interests include optimizing transfusion support for critically ill and hemorrhaging patients through the use of whole blood coagulation testing.
  
  Affiliation: Assistant Professor, Assistant Director of Blood Bank, Associate Director of Coagulation Laboratory, University of Chicago, Chicago, IL